Items where Subject is "Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > PHARMACOLOGY AND PHARMACEUTICAL SCIENCES (111500)"
 | Up a level |
- Subjects classification (32824)
- Australian and New Zealand Standard Research Classification (32824)
- MEDICAL AND HEALTH SCIENCES (110000) (6766)
- PHARMACOLOGY AND PHARMACEUTICAL SCIENCES (111500) (228)
- MEDICAL AND HEALTH SCIENCES (110000) (6766)
- Australian and New Zealand Standard Research Classification (32824)
Group by: Authors/Creators | Item Type
Number of items at this level: 181.
A
Adam, W. R., Craik, D. J., Kneen, M., & Wellard, R. Mark (1989) Effect of magnesium depletion and potassium and chlorothiazide on intracellular pH in the rat, studied by 31P NMR. Clinical and Experimental Pharmacology and Physiology, 16(1), pp. 33-40.
8
8Adams, Mark, Ramachandran, Rithwik, Yau, Mei-Kwan, Suen, Jacky, Fairlie, David, Hollenberg, Morley, et al. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacology and Therapeutics, 130(3), pp. 248-282.
39 39
39 39Algase, Donna, Beattie, Elizabeth, Song, Jun Ah, Milke, Doris, & Cowan, Bronwyn (2004) Validation of the Algase Wandering Scale (Version 2) in a cross cultural sample. Aging and Mental Health, 8(2), pp. 133-142.
16 13
16 13Algase, Donna, Yao, Lan, Son, Gwi Ryung, Beattie, Elizabeth, Beck, Cornelia, & Whall, Ann (2007) Initial psychometrics of the ambiance scale: A tool to study person-environment interaction in dementia. Aging and Mental Health, 11(3), pp. 266-272.
4 4
4 4Altamirano-Dimas, Manuel, Hudson, J., Cochrane, Dawn, Nelson, Colleen, & Arnason, J. (2007) Modulation of immune response gene expression by echinacea extracts: results of a gene array analysis. Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1091-1098.
14 10
14 10B
Batra, Jyotsna, Sharma, Surendra, & Ghosh, Balaram (2006) Arylamine N-acetyltransferase gene polymorphisms: markers for atopic asthma, serum IgE and blood eosinophil counts. Pharmacogenomics, 7(5), pp. 673-682.
14 13
14 13Beattie, Elizabeth, Algase, Donna, & Song, Jun Ah (2004) Keeping wandering nursing home residents at the table: improving food intake using a behavioral communication intervention. Aging and Mental Health, 8(2), pp. 109-116.
8 7
8 7Borgstedt, Johanna, Clark, Robyn, Morran, Jennifer, Colley, Desmond, & Shakib, Sepehr (2009) Pre-Admission and Post-Hospital Management of Heart Failure in Patients not Enrolled in Specialist Programs. Journal of Pharmacy Practice and Research, 39(3), pp. 186-191.
6
6C
Chan, Vincent, Fenning, Andrew, Hoey, Andrew, & Brown, Lindsay (2011) Chronic [beta]-adrenoceptor antagonist treatment controls cardiovascular remodeling in heart failure in the aging spontaneously hypertensive rat. Journal of Cardiovascular Pharmacology, 58(4), pp. 424-431.
2 3
2 3Chatterjee, Susmita & Bartlett, Selena (2010) Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. CNS and Neurological Disorders - Drug Targets, 9(1), pp. 60-76.
21 14
21 14Chatterjee, Susmita, Steensland, Pia, Simms, Jeffrey, Holgate, Joan, Coe, Jotham, Hurst, Raymond, et al. (2011) Partial agonists of the [alpha]3[beta]4[ast] neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. Neuropsychopharmacology, 36(3), pp. 603-615.
20
20Chen, Lu, Meyers, Deborah, Javorsky, George, Burstow, Darryl, Lolekha, Pakorn, Lucas, Margaret, et al. (2007) Arg389Gly-[beta]1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol. Pharmacogenetics and Genomics, 17(11), pp. 941-949.
34 29
34 29Chen, Yi, Hills, Brian, Hills, Yvette, & Mills, Paul (2005) Differences in Surfactant Lipids Collected from Pleural and Pulmonary Lining Fluids. Pharmaceutical Research, 22(11), pp. 1926-1930.
2 1
2 1Christ, Torsten, Molenaar, Peter, Klenowski, Paul, Ravens, Ursula, & Kaumann, Alberto J. (2011) Human atrial beta1L-adrenoceptor but not beta3-adrenoceptor activation increases force and Ca2+ current at physiological temperature. British Journal of Pharmacology, 162(4), pp. 823-839.
54 3 4
54 3 4D
Daniels, Lynne (2003) Good nutrition for good surgery: clinical and quality of life outcomes. Australian Prescriber, 26(6), pp. 136-140.
7
7Devine, Shane, Gregg, Alison, Figler, Heidi, McIntosh, Kate, Urmaliya, Vijay, Linden, Joel, et al. (2010) Synthesis and evaluation of new N6 - substituted adenosine-5'-N-methylcarbox-amides as A3 adenosine. Bioorganic & Medicinal Chemistry, 18(9), pp. 3078-3087.
6
6Doggrell, Sheila (2006) After the failure of citalopram for depression, what next? Expert Opinion on Pharmacotherapy, 7(11), pp. 1515-1518.
1 1
1 1Doggrell, Sheila (2012) Apixaban for the prevention of thromboembolism in adults after elective hip or knee replacement surgery, and in symptomatic venous thromboembolism. Clinical Medicine Reviews in Vascular Health, 4, pp. 19-28.
7
7Doggrell, Sheila (2005) Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleeding. Expert Opinion on Pharmacotherapy, 6(7), pp. 1253-1256.
4 3
4 3Doggrell, Sheila (2005) BG-9928 (Biogen Idec). Current Opinion in Investigational Drugs, 6(9), pp. 962-968.
9
9Doggrell, Sheila (2005) BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia. Expert Opinion on Investigational Drugs, 14(1), pp. 89-91.
25 24
25 24Doggrell, Sheila (2005) Berberine - a novel approach to cholesterol lowering. Expert Opinion on Investigational Drugs, 14(5), pp. 683-685.
21 20
21 20Doggrell, Sheila (2011) Bitter taste receptors as a target for bronchodilation. Expert Opinion on Therapeutic Targets, 15(7), pp. 899-902.
2 2
2 2Doggrell, Sheila (2005) Bradykinin B2 receptors - a target in diabetic nephropathy. Expert Opinion on Therapeutic Targets, 9(2), pp. 411-414.
5 5
5 5Doggrell, Sheila (2006) Bradykinin B2 receptors as a target in diabetic nephropathy. Current Opinion in Investigational Drugs, 7(3), pp. 251-255.
4
4Doggrell, Sheila (2005) CHARMed - the effects of candesartan in heart failure. Expert Opinion on Pharmacotherapy, 6(3), pp. 513-516.
Doggrell, Sheila (2005) CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction. Expert Opinion on Pharmacotherapy, 6(10), pp. 1761-1764.
2 2
2 2Doggrell, Sheila (2011) CX3CR1 as a target for airways inflammation. Expert Opinion on Therapeutic Targets, 15(9), pp. 1139-1142.
Doggrell, Sheila (2005) Calmodulin kinase II as a target for inhibition in cardiac disease. Expert Opinion on Therapeutic Targets, 9(6), pp. 1319-1321.
Doggrell, Sheila (2007) Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target? Current Opinion in Investigational Drugs, 8(9), pp. 742-749.
4 3
4 3Doggrell, Sheila (2008) Celecoxib to prevent restenosis - results from the COREA-TAXUS trial. Expert Opinion on Pharmacotherapy, 9(2), pp. 339-341.
Doggrell, Sheila (2006) Ceramide as a target in emphysema. Expert Opinion on Therapeutic Targets, 10(1), pp. 191-194.
Doggrell, Sheila (2005) Clinical evidence for drug treatments in obesity in hypertensive patients. Methods and Findings in Experimental and Clinical Pharmacology, 27(2), pp. 119-125.
4 4
4 4Doggrell, Sheila (2005) Clinical potential of nitric oxide-independent soluble guanylate cyclase activators. Current Opinion in Investigational Drugs, 6(9), pp. 874-878.
11
11Doggrell, Sheila (2008) Clinical trials with thiazolidinediones in subjects with Type 2 diabetes - is pioglitazone any different from rosiglitazone? Expert Opinion on Pharmacotherapy, 9(3), pp. 405-420.
9 9
9 9Doggrell, Sheila (2007) Clopidogrel use with stenting. Expert Opinion on Pharmacotherapy, 8(9), pp. 1399-1402.
1 2
1 2Doggrell, Sheila (2005) Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opinion on Pharmacotherapy, 6(1), pp. 75-84.
27 20
27 20Doggrell, Sheila (2005) Conivaptan (Yamanouchi). Current Opinion in Investigational Drugs, 6(3), pp. 317-326.
7
7Doggrell, Sheila (2005) Cytochrome P-450: a new target in the heart and coronary circulation. Drugs of the Future, 30(3), pp. 261-269.
3 3
3 3Doggrell, Sheila (2012) Dalcetrapib restoring belief in modulating CETP as a beneficial mechanism in cardiovascular disease. Expert Opinion in Investigational Drugs, 21(4), pp. 569-573.
13 1 1
13 1 1Doggrell, Sheila (2007) Does rosiglitazone increase cardiovascular outcomes? Expert Opinion on Pharmacotherapy, 8(15), pp. 2665-2669.
2 3
2 3Doggrell, Sheila (2012) Drug distribution, metabolism and elimination, and relationship to blood levels. In Doggrell, Sheila (Ed.) Pharmacology in one semester. eBook.
31
31Doggrell, Sheila (2012) Drugs and the autonomic nervous system. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
24
24Doggrell, Sheila (2012) Drugs and the gastrointestinal tract. Pharmacology in One Semester. (Unpublished)
44
44Doggrell, Sheila (2012) Drugs and the respiratory system. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
38
38Doggrell, Sheila (2012) Drugs for cardiac arrhythmmias, antithrombotic drugs and lipid modulating drugs. Pharmacology in one semester.
12
12Doggrell, Sheila (2012) Drugs for hypertension, angina and heart failure. Pharmacology in One Semester.
35
35Doggrell, Sheila (2005) Farnesoid X receptor agonism - a new approach to the treatment of cholesterol gallstone disease. Expert Opinion on Investigational Drugs, 14(4), pp. 535-538.
1 1
1 1Doggrell, Sheila (2005) Fluoxetine - do the benefits outweigh the risks in adolescent major depression? Expert Opinion on Pharmacotherapy, 6(1), pp. 147-150.
6 4
6 4Doggrell, Sheila (2005) Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved? Expert Opinion on Pharmacotherapy, 6(5), pp. 831-834.
2 1
2 1Doggrell, Sheila (2006) Inhibition of RANKL: a new approach to the treatment of osteoporosis. Expert Opinion on Pharmacotherapy, 7(8), pp. 1097-1100.
1
1Doggrell, Sheila (2006) Inhibitors of cholesteryl ester transfer protein - a new approach to coronary artery disease. Expert Opinion on Investigational Drugs, 15(2), pp. 99-106.
16 11
16 11Doggrell, Sheila (2005) Inhibitors of cholesteryl ester transfer protein - a step forward in the treatment of coronary artery disease? Drugs of the Future, 30(1), pp. 45-50.
1
1Doggrell, Sheila (2012) Introduction to pharmacology, and routes of drug administration. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Sheila Doggrell.
50
50Doggrell, Sheila (2005) Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia? Expert Opinion on Investigational Drugs, 14(8), pp. 1063-1066.
3 4
3 4Doggrell, Sheila (2006) Is NXY-059 an advancement in the treatment of acute ischaemic stroke? Expert Opinion on Pharmacotherapy, 7(7), pp. 965-968.
Doggrell, Sheila (2006) Is amlodipine the best initial monotherapy for hypertension? Expert Opinion on Pharmacotherapy, 7(6), pp. 829-832.
2 2
2 2Doggrell, Sheila (2006) Is exenatide advancing the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(1), pp. 109-112.
3 3
3 3Doggrell, Sheila (2007) Is fingolimod an advancement in the treatment of multiple sclerosis? Expert Opinion on Pharmacotherapy, 8(3), pp. 383-386.
3 2
3 2Doggrell, Sheila (2008) Is long-term adjuvant treatment of breast cancer with anastrozole indicated? Expert Opinion on Pharmacotherapy, 9(9), pp. 1619-1622.
3 1
3 1Doggrell, Sheila (2008) Is rimonabant efficacious and safe in the treatment of obesity? Expert Opinion on Pharmacotherapy, 9(15), pp. 2727-2731.
14 13
14 13Doggrell, Sheila (2008) Is sapropterin treatment suitable for all subjects with phenylketonuria? Expert Opinion on Pharmacotherapy, 9(1), pp. 145-147.
5 2
5 2Doggrell, Sheila (2005) Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity? Expert Opinion on Pharmacotherapy, 6(12), pp. 2141-2144.
Doggrell, Sheila (2008) Is tocilizumab an option for the treatment of arthritis? Expert Opinion on Pharmacotherapy, 9(11), pp. 2009-2013.
Doggrell, Sheila (2011) Lemur tyrosine kinase-3 (LMTK3) as a target in oestrogen positive breast cancer. Expert Opinion on Therapeutic Targets, 15(12), pp. 1419-1422.
Doggrell, Sheila (2007) Misoprostol for the treatment of early pregnancy failure. Current Clinical Pharmacology, 2(1), pp. 1-9.
2
2Doggrell, Sheila (2012) More light at the end of the tunnel – apixaban in atrial fibrillation. Expert Opinion in Investigational Drugs, 13(10), pp. 1470-1480.
19
19Doggrell, Sheila (2005) More support for high-dose atorvastatin in coronary artery disease. Expert Opinion on Pharmacotherapy, 6(13), pp. 2365-2368.
Doggrell, Sheila (2006) Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(9), pp. 1229-1233.
4 5
4 5Doggrell, Sheila (2005) NF-(kappa)B - a target in the inflammation of bone destruction. Expert Opinion on Therapeutic Targets, 9(1), pp. 191-193.
1 1
1 1Doggrell, Sheila (2006) Natalizumab in multiple sclerosis: proceed with caution? Expert Opinion on Pharmacotherapy, 7(12), pp. 1675-1678.
2 2
2 2Doggrell, Sheila (2012) Neurological drugs and opioids for pain management. In Doggrell, Sheila (Ed.) Pharmacology in One semester.
26
26Doggrell, Sheila (2005) Neuromedin U - a new target in obesity. Expert Opinion on Therapeutic Targets, 9(4), pp. 875-877.
6 5
6 5Doggrell, Sheila (2007) New drugs and new targets down under in 2006: highlights from the 3rd Australian Health and Medical Research Congress. Drugs of the Future, 32(1), pp. 93-102.
Doggrell, Sheila (2005) New drugs being developed for the treatment of tuberculosis. Expert Opinion on Investigational Drugs, 14(7), pp. 917-920.
5 4
5 4Doggrell, Sheila (2008) New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture. Expert Opinion on Pharmacotherapy, 9(4), pp. 663-668.
Doggrell, Sheila (2008) New indications for topiramate: alcohol dependency and binge-eating disorder. Expert Opinion on Pharmacotherapy, 9(5), pp. 869-873.
3 1
3 1Doggrell, Sheila (2006) New targets in and potential treatments for cholesterol gallstone disease. Current Opinion in Investigational Drugs, 7(4), pp. 344-348.
7 5
7 5Doggrell, Sheila (2006) Nitrone spin on cerebral ischemia. Current Opinion in Investigational Drugs, 7(1), pp. 20-24.
4 4
4 4Doggrell, Sheila (2007) Novel drugs and products in neuroscience: highlights from IBRO. Drugs of the Future, 32(11), pp. 1007-1017.
Doggrell, Sheila (2006) Partial agonism at nicotinic receptors with varenicline - a new approach to smoking cessation. Expert Opinion on Pharmacotherapy, 7(18), pp. 2599-2603.
1
1Doggrell, Sheila (2005) Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration. Expert Opinion on Pharmacotherapy, 6(8), pp. 1421-1423.
27 25
27 25Doggrell, Sheila (2012) Pharmacodynamics. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
14
14Doggrell, Sheila (2012) Pharmacovigilance and pharmacogenetics. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
19
19Doggrell, Sheila (2006) Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. Expert Opinion on Pharmacotherapy, 7(4), pp. 485-488.
1 2
1 2Doggrell, Sheila (2005) Phosphodiesterase 5A as a target in cardiac disease. Expert Opinion on Therapeutic Targets, 9(5), pp. 1097-1100.
2 2
2 2Doggrell, Sheila (2006) Phosphoinositide 3-kinase-gamma as a target in rheumatoid arthritis and systemic lupus. Expert Opinion on Therapeutic Targets, 10(4), pp. 627-630.
1 1
1 1Doggrell, Sheila (2012) Poisoning with drugs. In Doggrell, Sheila (Ed.) Pharmacology in one semester. Doggrell, Sheila.
14
14Doggrell, Sheila (2005) Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours. Expert Opinion on Investigational Drugs, 14(12), pp. 1561-1564.
Doggrell, Sheila (2005) Pregabalin or morphine and gabapentin for neuropathic pain. Expert Opinion on Pharmacotherapy, 6(14), pp. 2535-2539.
4 3
4 3Doggrell, Sheila (2006) Recent evidence of sustained benefit with exenatide in Type 2 diabetes. Expert Opinion on Pharmacotherapy, 7(14), pp. 2003-2006.
6 5
6 5Doggrell, Sheila (2005) Recent findings with docetaxel in postoperative treatment for breast cancer. Expert Opinion on Pharmacotherapy, 6(16), pp. 2903-2906.
Doggrell, Sheila (2005) Recent important trials of pharmacotherapy in Parkinson's disease. Expert Opinion on Pharmacotherapy, 6(6), pp. 1025-1028.
Doggrell, Sheila (2005) Relating statin therapy to C-reactive protein levels. Expert Opinion on Pharmacotherapy, 6(9), pp. 1597-1600.
7 7
7 7Doggrell, Sheila (2005) Rho-kinase inhibitors show promise in pulmonary hypertension. Expert Opinion on Investigational Drugs, 14(9), pp. 1157-1159.
12 9
12 9Doggrell, Sheila (2007) Rosiglitazone: rosy news for a thiazolidinedione. Expert Opinion on Pharmacotherapy, 8(2), pp. 265-268.
1
1Doggrell, Sheila (2006) Sibutramine for obesity in adolescents. Expert Opinion on Pharmacotherapy, 7(17), pp. 2435-2438.
1 1
1 1Doggrell, Sheila (2006) 'Simply stunning' - trastuzumab in HER2-positive breast cancer. Expert Opinion on Pharmacotherapy, 7(5), pp. 631-634.
3 3
3 3Doggrell, Sheila (2006) Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation. Expert Opinion on Pharmacotherapy, 7(2), pp. 225-228.
2
2Doggrell, Sheila (2011) Sitagliptin or exenatide once weekly for type 2 diabetes: Comparison of the clinical trials. Expert Opinion on Pharmacotherapy, 12(13), pp. 2055-2067.
1 1
1 1Doggrell, Sheila (2012) Smoking cessation. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
12
12Doggrell, Sheila (2005) Stabilisation of calstabin2 - a new approach in sudden cardiac death. Expert Opinion on Therapeutic Targets, 9(5), pp. 955-962.
4 3
4 3Doggrell, Sheila (2005) Taking the 20-HETE out of the cardiovascular system: The potential of 20-HETE synthesis inhibitors. Current Opinion in Investigational Drugs, 6(9), pp. 901-906.
2
2Doggrell, Sheila (2008) Therapeutic potential of non-peptide chymase inhibitors. Expert Opinion on Therapeutic Patents, 18(5), pp. 485-499.
2 1
2 1Doggrell, Sheila (2011) Treatment for relapsed Hodgkin lymphoma: Refinement of chemotherapy or targeted treatment? Expert Opinion on Pharmacotherapy, 12(6), pp. 991-994.
Doggrell, Sheila (2005) Which drug combination for hormone-refractory prostate cancer? Expert Opinion on Pharmacotherapy, 6(4), pp. 667-670.
1 1
1 1Doggrell, Sheila (2007) Which is the best primary medication for long-term smoking cessation - nicotine replacement therapy, bupropion or varenicline? Expert Opinion on Pharmacotherapy, 8(17), pp. 2903-2915.
6 5
6 5Doggrell, Sheila (2006) Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention? Expert Opinion on Pharmacotherapy, 7(15), pp. 2169-2173.
2 3
2 3Doggrell, Sheila (2005) Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert Opinion on Investigational Drugs, 14(3), pp. 339-342.
12 7
12 7Doggrell, Sheila (2005) Ximelagatran - recent comparisons with warfarin. Expert Opinion on Pharmacotherapy, 6(11), pp. 1943-1946.
1 1
1 1Doggrell, Sheila (2012) The ezetimibe controversy? Can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? Expert Opinion on Pharmacotherapy, 13(10), pp. 1469-1480.
27 4 5
27 4 5Doggrell, Sheila (2011) A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2. Expert Opinion on Investigational Drugs: authoritative analysis of R&D trends, 20(4), pp. 587-590.
1
1Doggrell, Sheila (2005) The nitrosterols - a step forward from the steroid anti-inflammatory drugs? Expert Opinion on Investigational Drugs, 14(7), pp. 823-828.
5 4
5 4Doggrell, Sheila (2005) The safety of lumiracoxib when used in the treatment of arthritis. Expert Opinion on Pharmacotherapy, 6(2), pp. 347-350.
7 6
7 6Doggrell, Sheila (2005) A small-molecule lead compound for the treatment of Alzheimer's disease. Expert Opinion on Investigational Drugs, 14(2), pp. 199-201.
Doggrell, Sheila & Christensen, Anne-Marie (2011) Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Expert Opinion on Pharmacotherapy, 12(1), pp. 157-163.
2 1
2 1Doggrell, Sheila & Davis, Elisabeth (2012) Anti-infectives. In Doggrell, Sheila (Ed.) Pharmacology in One semester.
31
31Doggrell, Sheila & Hancox, Jules (2005) Ibutilide - recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opinion on Investigational Drugs, 14(5), pp. 655-669.
3 2
3 2Doggrell, Sheila & Hancox, Jules (2012) PALLAS : limiting indications for dronedarone treatment of atrial fibrillation. Expert Opinion on Pharmacotherapy, 13(6), pp. 1-5.
10
10Doggrell, Sheila & Hart, Joaane L. (2012) Drugs Used to Treat Endocrine Disorders. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
36
36Doggrell, Sheila & Kairuz, Therese (2012) Medicine management by the older-aged living independently in different types of retirement villages. Journal of Pharmacy Practice and Research, 42, pp. 208-212.
16
16Doggrell, Sheila & Wanstall, Janet (2005) Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors. Canadian Journal of Physiology and Pharmacology, 83(2), pp. 123-130.
28 23
28 23Domschke, Katharina, Dannlowski, Udo, Ohrmann, Patricia, Lawford, Bruce, Bauer, Jochen, Kugel, Harald, et al. (2008) Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression. European Neuropsychopharmacology, 18(10), pp. 751-759.
46 40
46 40E
Ekmekci, Yasemin, Bohms, Andreas, Thomson, Jennifer, & Mundree, Sagadevan (2005) Photochemical and antioxidant responses in the leaves of xerophyta viscosa Baker and digitaria sanguinalis L. under water deficit. Zeitschrift fuer Naturforschung, Section C: A Journal of Biosciences, 60c, pp. 435-443.
9 5
9 5F
Fairweather, Jon, Hammond, Edward, Johnstone, Ken, & Ferro, Vito (2008) Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88. Bioorganic and Medicinal Chemistry, 16(2), pp. 699-709.
20 18
20 18Feduccia, Allison A., Chatterjee, Susmita, & Bartlett, Selena E. (2012) Neuronal nicotinic acetylcholine receptors : neuroplastic changes underlying alcohol and nicotine addictions. Frontiers in Molecular Neuroscience, 5(83), pp. 1-19.
13
13G
Gleave, Martin, Nelson, Colleen, & Chi, Kim (2003) Antisense targets to enhance hormone and cytotoxic therapies in advanced prostate cancer. Current Drug Targets, 4(3), pp. 209-221.
19 19
19 19Green, Bob, Kavanagh, David J., & Young, Ross McD. (2003) Being stoned : a review of self-reported cannabis effects. Drug and Alcohol Review, 22(4), pp. 453-460.
67 61
67 61H
Haass-Koffler, Carolina L. & Bartlett, Selena E. (2012) Stress and addiction : contribution of the corticotropin releasing factor (CRF) system in neuroplasticity. Frontiers in Molecular Neuroscience, 5(91), pp. 1-19.
35
35Hancox, Jules & Doggrell, Sheila (2010) Perspective: Does ranolazine have potential for the treatment of atrial fibrillation? Expert Opinion on Investigational Drugs, 19(12), pp. 1465-1474.
Hariyadi, Dewi, Lin, Sharon, Wang, Yiwei, Bostrom, Thor, Turner, Mark, Bhandari, Bhesh, et al. (2010) Diffusion loading and drug delivery characteristics of alginate gel microparticles produced by a novel impinging aerosols method. Journal of Drug Targeting, 18(10), pp. 831-841.
4 4
4 4Hartley, Patrick, Islam, Nazrul, Larson, Ian, & Stewart, Peter (2005) Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy. Journal of Pharmaceutical Sciences, 94(7), pp. 1500-1511.
30 29
30 29Hickey, Danica, Bao, Shisan, Ikeda, Luke, Carey, Alison, & Beagley, Kenneth (2005) Induction of anti-chlamydial mucosal immunity by transcutaneous immunization is enhanced by topical application of GM-CSF. Current Molecular Medicine, 5(6), pp. 599-605.
12 9
12 9Hinton, Tina & Johnston, Graham (2012) Alcohol. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
4
4Hughes, Louise, Griffith, Renate, Carey, Alison, Butler, Trent, Donne, Scott, Beagley, Kenneth, et al. (2009) The spermostatic and microbicidal actions of quinones and malemides: towards a dual-purpose contraceptive agent. Molecular Pharmacology, 76(1), pp. 113-124.
11 13
11 13J
Johnstone, Ken, Karoli, Tomislav, Liu, Ligong, Dredge, Keith, Copeman, Elizabeth, Li, Cai Ping, et al. (2010) Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth. Journal of Medicinal Chemistry, 53(4), pp. 1686-1699.
15 16
15 16K
Karoli, Tomislav, Liu, Ligong, Fairweather, Jon, Hammond, Edward, Li, Cai Ping, Cochran, Siska, et al. (2005) Synthesis, Biological Activity and Preliminary Pharmacokinetic Evaluation of Analogues of a Phosphosulfomannan Angiogenesis Inhibitor (PI-88). Journal of Medicinal Chemistry, 48(26), pp. 8229-8236.
38 37
38 37Kaspar, Daniela, Schwarz, Winfried, Claes, Lutz, & Ignatius, Anita (2006) Study of the toxicity of povidone-iodine for fibroblast-like cells (BALB-3T3) and primary human chondrocytes (Untersuchung der Toxizitat von Polyvinyl-Pyrrolidon-Jod an fibroblastaren Zellen (BALB-3T3) und primären humanen Knorpelzellen). Arzneimittel-Forschung / Drug Research, 56(8), pp. 605-611.
3
3Kaumann, Alberto, Semmler, Annalese, & Molenaar, Peter (2007) The effects of both noradrenaline and CGP12177, mediated through human Beta1-adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells. Naunyn-Schmiedebergs Archives of Pharmacology, 375(2), pp. 123-131.
14 13
14 13Kavanagh, David J. (1993) The psychological management of adult grief reactions. Australian Prescriber, 16(4), pp. 87-89.
Khan, Sohil, Heussler, Honey, McGuire, Treasure, Dakin, Carolyn, Pache, David, Norris, Ross, et al. (2011) Therapeutic options in the management of sleep disorders in visually impaired children: A systematic review. Clinical Therapeutics: the international peer-reviewed journal of drug therapy, 33(2), pp. 168-181.
1 1
1 1Kiriakous, Emad (2007) Chiral discrimination and enantioselective analysis of drugs: An overview. Journal of Pharmaceutical Sciences, 96(7), pp. 1659-1676.
48 49
48 49Klenowski, P., Semmler, A., Chee, K., Iconomou, M., & Molenaar, P. (2010) Contribution of transmembrane domain V amino acids to β1l-adrenoceptor activity and affinity. In Ngo, Suong, Hay, Debbie, & Polasek, Tom (Eds.) Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 44th Annual Scientific Meeting, 28th November 2010 - 1st December 2010, Melbourne.
11
11Klenowski, Paul, Semmler, A., Chee, K., Iconomou, Mary, & Molenaar, Peter (2010) Contribution of transmembrane domain V amino acids to β1l-adrenoceptor activity and affinity. In Drug Discovery Biology, Monash University : Molecular Pharmacology of G Protein-Coupled Receptors meeting 2010, December 2nd - 4th, 2010, Monash Institute of Pharmaceutical Sciences.
11
11L
Lapworth, Kely, Dawe, Sharon, Davis, Penelope, Kavanagh, David, Young, Ross, & Saunders, John (2009) Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users. Addictive Behaviors, 34(4), pp. 380-385.
17 16
17 16Levin, Edward, Aschner, Michael, Heberlein, Ulrike, Ruden, Douglas, Welsh-Bohmer, Kathleen, Bartlett, Selena, et al. (2009) Genetic aspects of behavioral neurotoxicology. NeuroToxicology, 30(5), pp. 741-753.
8 8
8 8Lim, Su Lin, Lee, Evan Jon-Choon, Myint, C.C., Ong, K.T., Tay, M.E., Yusuf, N, et al. (2001) Oral intake and serum levels of ascorbic acid in continuous ambulatory peritoneal dialysis patients. Advances in Peritoneal Dialysis, 17, pp. 215-218.
49 10
49 10Liu, Ligong, Bytheway, Ian, Karoli, Tomislav, Fairweather, Jon, Cochran, Siska, Li, Cai Ping, et al. (2008) Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides. Bioorganic and Medicinal Chemistry Letters, 18(1), pp. 344-349.
8 9
8 9Lovgren, S., Clark, Robyn., Angley, Manya., Ponniah, Anne., Colley, Desmond., & Shakib, Sepehr. (2009) Timeliness and Clinical Impact of Hospital-Initiated Medication Reviews. Journal of Pharmacy Practice and Research, 39(4), pp. 269-273.
14 2
14 2M
McGree, James, Eccleston, John, & Duffull, Stephen (2008) Compound optimal design criteria for nonlinear models. Journal of Biopharmaceutical Statistics, 18(4), pp. 646-661.
9 10
9 10McGree, James, Eccleston, John, & Duffull, Stephen (2009) Simultaneous versus sequential optimal design for pharmacokinetic-pharmacodynamic models with FO and FOCE considerations. Journal of Pharmacokinetics and Pharmacodynamics, 36(2), pp. 101-123.
3 4
3 4Molenaar, Peter, Chen, Lu, Semmler, Annalese, Parsonage, William, & Kaumann, Alberto (2007) Human heart Beta-adrenoceptors:-Beta1-adrenoceptor diversification through 'affinity states' and polymorphism. Clinical and Experimental Pharmacology and Physiology, 34(10), pp. 1020-1028.
18 11
18 11Molenaar, Peter, Savarimuthu, Santiyagu, Sarsero, Doreen, Chen, Lu, Semmler, Annalese, Carle, Anne, et al. (2007) (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through Beta2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling. Naunyn-Schmiedeberg's Archives of Pharmacology, 375(1), pp. 11-28.
16 16
16 16Mullaney, Ian (2012) Drugs affecting blood. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
31
31Mullaney, Ian (2012) Drugs in pregnancy and labour. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
20
20Mullaney, Ian (2012) An introduction to anticancer drugs. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
28
28Mullaney, Ian (2012) An introduction to biologics. In Doggrell, Sheila (Ed.) Pharmacology in One Semester.
28
28N
Nielsen, C. K., Simms, J. A., Li, R., Mill, D., Yi, H., Feduccia, A. A., et al. (2012) Delta opioid-receptor function in the dorsal striatum plays a role in high levels of ethanol consumption in rats. Journal of Neuroscience, 32(13), pp. 4540-4552.
P
Patounas, Marea & McGuire, Treasure M (2007) Starter packs : a good start to therapy. Australian Prescriber, 30(1), pp. 14-16.
5
5R
Richards, Jemma, Simms, Jeffrey, Steensland, Pia, Taha, Sharif, Borgland, Stephanie, Bonci, Antonello, et al. (2008) Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology, 199(1), pp. 109-117.
82 73
82 73Ryall, James, Sillence, Martin, & Lynch, Gordon (2006) Systemic administration of (beta)2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. British Journal of Pharmacology, 147(6), pp. 587-595.
40 42
40 42S
Sanderson, Thomas, Renaud, Martin, Scholten, Deborah, Nijmeijer, Sandra, van den Berg, Martin, Cowell, Simon, et al. (2008) Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells. European Journal of Pharmacology, 593(1-3), pp. 92-98.
3 3
3 3Santos, Nathan, Chatterjee, Susmita, Henry, Andrea, Holgate, Joan, & Bartlett, Selena (2012) The α5 neuronal nicotinic acetylcholine receptor subunits plays an important role in the sedative effects of ethanol but does not modulate consumption in mice. Alcoholism : Clinical and Experimental Research.
Scott, Rebecca, Hides, Leanne, Sabura Allen, J., Burke, Richard, & Lubman, Daniel (2010) Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use. Psychopharmacology, 209(1), pp. 25-36.
5 5
5 5Shehan, B.P., Wellard, R.M., Craik, D.J., & Adam, W.R. (1995) 133Cs relaxation times in rat tissues. Journal of Magnetic Resonance, Series B, 107(2), pp. 179-185.
4 5
4 5Smith, Simon S., Dingwall, Kylie, Jorgensen, Greg, & Douglas, James (2006) Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea. Journal of Clinical Sleep Medicine, 2(2), pp. 156-162.
9
9Srinivasan, Subhashini, Simms, Jeff, Nielsen, Carsten, Lieske, Steven, Bito-Ono, Jade, Yi, Henry, et al. (2012) The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration. PloS ONE, 7(9).
T
Tugiono, N., Kiriazis, H., Gao, X., Xu, Q., Jennings, N., Molenaar, P., et al. (2010) Role of low affinity beta1-adrenergic receptors in normal and diseased hearts. In Jeremy, Richard (Ed.) Cardiac Society of Australia and New Zealand Annual Scientific Meeting and International Society for Heart Research Australasian Section Annual Scientific Meeting, 5-8 August 2010, Adelaide Convention Centre, Adelaide.
Tuli, Rinku A., Dargaville, Tim R., George, Graeme A., & Islam, Nazrul (2012) Polycaprolactone microspheres as carriers for dry powder inhalers : effect of surface coating on aerosolization of salbutamol sulfate. Journal of Pharmaceutical Sciences, 101(2), pp. 733-745.
1 1
1 1Turner, Mark, Andersson, Patiyan, Bell, Jan, Turnidge, John, Harris, Tegan, & Giffard, Philip (2009) Plasmid-borne blaSHV genes in Klebsiella pneumoniae are associated with strong promoters. Journal of Antimicrobial Chemotherapy, 64(5), pp. 960-964.
1
1V
Vingilis, Evelyn & MacDonald, Scott (2000) Medicinal drugs and traffic collisions: Evidence, issues and challenges. In Road Safety Research, Policing and Education Conference, 26-28 November 2000, Brisbane, Queensland.
W
Wanstall, Janet, Homer, Kerry, & Doggrell, Sheila (2005) Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Current Vascular Pharmacology, 3(1), pp. 41-53.
42
42Z
Zhang, Qiulan, Ni, Yongnian, & Kokot, Serge (2010) Molecular spectroscopic studies on the interaction between Ractopamine and bovine serum albumin. Journal of Pharmaceutical and Biomedical Analysis, 52(2), pp. 280-288.
18 15
18 15